Blood lead, bone lead, and adult cognitive function through its relationship with depressive symp- toms, hypertension, or homocysteine levels, all of which inﬂuence cognitive impairment and risk of dementia. Future investigations should explicitly account for these complex causal pathways, and also determine whether chronic effects of cumulative lead dose increases the risk for such clinically relevant syndromes as mild cognitive impairment (Petersen et al. 1999). REFERENCES Agency for Toxic Substances and Disease Registry. 1999. Toxicological Profile for Lead. Update, 1999. Atlanta: Agency for Toxic Substances and Disease Registry. American Psychological Association. 2006. PsychINFO Database. Available: http://www.apa.org/psycinfo/ [accessed 24 August 2006]. Annest JL, Pirkle JL, Makuc D, Neese JW, Bayse DD, Kovar MG. 1983. Chronological trend in blood lead levels between 1976 and 1980. N Engl J Med 308(23):1373–1377. Arnett PA, Higginson CI, Voss WD, Bender WI, Wurst JM, Tippin JM. 1999. Depression in multiple sclerosis: relation- ship to working memory capacity. Neuropsychology 13(4): 546–556. Baker EL, Feldman RG, White RF, Harley JP. 1983. The role of occupational lead exposure in the genesis of psychiatric and behavioral disturbances. Acta Psychiatr Scand Suppl 303:38–48. Balbus-Kornfeld JM, Stewart W, Bolla KI, Schwartz BS. 1995. Cumulative exposure to inorganic lead and neurobehav- ioural test performance in adults: an epidemiological review. Occup Environ Med 52(1):2–12. Barth A, Schaffer AW, Osterode W, Winker R, Konnaris C, Valic E, et al. 2002. Reduced cognitive abilities in lead-exposed men. Int Arch Occup Environ Health 75(6):394–398. Birkenhager WH, Staessen JA. 2006. Progress in cardiovascu- lar diseases: cognitive function in essential hypertension. Prog Cardiovasc Dis 49(1):1–10. Bleecker ML, Ford DP, Lindgren KN, Hoese VM, Walsh KS, Vaughan CG. 2005. Differential effects of lead exposure on components of verbal memory. Occup Environ Med 62(3): 181–187. Bleecker ML, Lindgren KN, Ford DP. 1997. Differential contribution of current and cumulative indices of lead dose to neuropsy- chological performance by age. Neurology 48(3):639–645. Chia SE, Chia HP, Ong CN, Jeyaratnam J. 1997. Cumulative blood lead levels and neurobehavioral test performance. Neurotoxicology 18(3):793–803. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. 1993. Gene dose of apolipopro- tein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261(5123):921–923. Cory-Slechta DA. 1995. Relationships between lead-induced learning impairments and changes in dopaminergic, cholin- ergic, and glutamatergic neurotransmitter system functions. Annu Rev Pharmacol Toxicol 35:391–415. Derogatis LR, Melisaratos N. 1983. The Brief Symptom Inventory: an introductory report. Psychol Med 13(3):595–605. Dufouil C, Alperovitch A, Ducros V, Tzourio C. 2003. Homo- cysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 53(2):214–221. Eichenbaum H. 2001. The hippocampus and declarative mem- ory: cognitive mechanisms and neural codes. Behav Brain Res 127(1–2):199–207. Ferguson C, Kern M, Audesirk G. 2000. Nanomolar concentra- tions of inorganic lead increase Ca2+ efﬂux and decrease intracellular free Ca2+ ion concentrations in cultured rat hippocampal neurons by a calmodulin-dependent mecha- nism. Neurotoxicology 21(3):365–378. Finkelstein Y, Markowitz ME, Rosen JF. 1998. Low-level lead- induced neurotoxicity in children: an update on central ner- vous system effects. Brain Res Rev 27(2):168–176. Folstein MF, Folstein SE, McHugh PR. 1975. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198. Glenn BS, Bandeen-Roche K, Lee BK, Weaver VM, Todd AC, Schwartz BS. 2006. Changes in systolic blood pressure associated with lead in blood and bone. Epidemiology 17(5):538–544. Glenn BS, Stewart WF, Links JM, Todd AC, Schwartz BS. 2003. The longitudinal association of lead with blood pressure. Epidemiology 14(1):30–36. Goodman M, LaVerda N, Clarke C, Foster ED, Iannuzzi J, Mandel J. 2002. Neurobehavioural testing in workers occupationally exposed to lead: systematic review and meta-analysis of publications. Occup Environ Med 59(4):217–223. Goodman M, LaVerda N, Mandel J. 2001. Commentary on “A meta-analysis for neurobehavioural results due to occupa- tional lead exposure with blood lead concentrations <70 microg/100 ml” by M. Meyer-Baron and A. Seeber. Arch Toxicol 75(7):439–442. Guallar E, Silbergeld EK, Navas-Acien A, Malhotra S, Astor BC, Sharrett AR, et al. 2006. Confounding of the relation between homocysteine and peripheral arterial disease by lead, cad- mium, and renal function. Am J Epidemiol 163(8):700–708. Hanninen H, Aitio A, Kovala T, Luukkonen R, Matikainen E, Mannelin T, et al. 1998. Occupational exposure to lead and neuropsychological dysfunction. Occup Environ Med 55(3): 202–209. Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, et al. 2006. Vascular risk factors for inci- dent Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord 20(2):93–100. Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD. 2002. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 59(5):787–793. Hoppin JA, Aro A, Hu H, Ryan PB. 2000. Measurement variability associated with KXRF bone lead measurement in young adults. Environ Health Perspect 108:239–242. Hoppin JA, Aro AC, Williams PL, Hu H, Ryan PB. 1995. Validation of K-XRF bone lead measurement in young adults. Environ Health Perspect 103:78–83. Hu H, Shih R, Rothenberg S, Schwartz BS. 2007. The epidemiol- ogy of lead toxicity in adults: measuring dose and consid- eration of other methodologic issues. Environ Health Perspect 115:455–462. Jorm AF. 2000. Is depression a risk factor for dementia or cogni- tive decline? A review. Gerontology 46(4):219–227. Kosnett MJ, Wedeen RP, Rothenberg SJ, Hipkins KL, Materna BL, Schwartz BS, et al. 2007. Recommendations for medical man- agement of adult lead exposure. Environ Health Perspect 115:463–471. Lindgren KN, Masten VL, Ford DP, Bleecker ML. 1996. Relation of cumulative exposure to inorganic lead and neuropsychologi- cal test performance. Occup Environ Med 53(7):472–477. Links JM, Schwartz BS, Simon D, Bandeen-Roche K, Stewart WF. 2001. Characterization of toxicokinetics and toxicodynamics with linear systems theory: application to lead-associated cognitive decline. Environ Health Perspect 109(4):361–368. Lucchini R, Albini E, Cortesi I, Placidi D, Bergamaschi E, Traversa F, et al. 2000. Assessment of neurobehavioral performance as a function of current and cumulative occupational lead exposure. Neurotoxicology 21(5):805–811. Maizlish NA, Parra G, Feo O. 1995. Neurobehavioral evaluation of Venezuelan workers exposed to inorganic lead. Occup Environ Med 52:408–414. Martin D, Glass TA, Bandeen-Roche K, Todd AC, Shi W, Schwartz BS. 2006. Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults. Am J Epidemiol 163(5):467–478. Mayeux R, Ottman R, Maestre G, Ngai C, Tang MX, Ginsberg H, et al. 1995. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer’s dis- ease. Neurology 45(3 pt 1):555–557. McCaddon A, Hudson P, Hill D, Barber J, Lloyd A, Davies G, et al. 2003. Alzheimer’s disease and total plasma aminothiols. Biol Psychiatry 53(3):254–260. McCaddon A, Kelly CL. 1992. Alzheimer’s disease: a ‘cobalamin- ergic’ hypothesis. Med Hypotheses 37(3):161–165. McNair DM, Lorr M, Droppelman LF. 1971. Manual for the Proﬁle of Mood States. San Diego, CA:Educational and Industrial Testing Service. Meyer MR, Tschanz JT, Norton MC, Welsh-Bohmer KA, Steffens DC, Wyse BW, et al. 1998. APOE genotype predicts when— not whether—one is predisposed to develop Alzheimer dis- ease. Nat Genet 19(4):321–322. Meyer-Baron M, Seeber A. 2000. A meta-analysis for neuro- behavioural results due to occupational lead exposure with blood lead concentrations <70 microg/100 ml. Arch Toxicol 73(10–11):510–518. Miyata M, Smith JD. 1996. Apolipoprotein E allele-specific Environmental Health Perspectives • VOLUME 115 | NUMBER 3 | March 2007 antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14(1):55–61. Moffat SD, Szekely CA, Zonderman AB, Kabani NJ, Resnick SM. 2000. Longitudinal change in hippocampal volume as a func- tion of apolipoprotein E genotype. Neurology 55(1):134–136. Naismith SL, Hickie IB, Turner K, Little CL, Winter V, Ward PB, et al. 2003. Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors. J Clin Exp Neuropsychol 25(6):866–877. Nash D, Magder L, Lustberg M, Sherwin RW, Rubin RJ, Kaufmann RB, et al. 2003. Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA 289(12):1523–1532. National Library of Medicine. 2006. PubMed Database. Available: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?DB=pubmed [accessed 24 August 2006]. Osterberg K, Borjesson J, Gerhardsson L, Schutz A, Skerfving S. 1997. A neurobehavioural study of long-term occupational inorganic lead exposure. Sci Total Environ 201(1):39–51. Parnetti L, Bottiglieri T, Lowenthal D. 1997. Role of homocysteine in age-related vascular and non-vascular diseases. Aging (Milano) 9(4):241–257. Payton M, Riggs KM, Spiro A, III, Weiss ST, Hu H. 1998. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicol Teratol 20(1):19–27. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. 1999. Mild cognitive impairment: clinical charac- terization and outcome. Arch Neurol 56(3):303–308. Pirkle JL, Kaufmann RB, Brody DJ, Hickman T, Gunter EW, Paschal DC. 1998. Exposure of the U.S. population to lead, 1991–1994. Environ Health Perspect 106:745–750. Poirier J, Sevigny P. 1998. Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer’s disease. J Neural Transm Suppl 53:199–207. Radloff LS. 1977. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Measurement 1:385–401. Ramesh GT, Manna SK, Aggarwal BB, Jadhav AL. 2001. Lead exposure activates nuclear factor kappa B, activator pro- tein-1, c-Jun N-terminal kinase and caspases in the rat brain. Toxicol Lett 123(2–3):195–207. Rhodes D, Spiro A III, Aro A, Hu H. 2003. Relationship of bone and blood lead levels to psychiatric symptoms: the normative aging study. J Occup Environ Med 45(11):1144–1151. Salthouse TA. 1996. General and specific speed mediation of adult age differences in memory. J Gerontol B Psychol Sci Soc Sci 51(1):P30–42. Salthouse TA. 1996. The processing-speed theory of adult age differences in cognition. Psychol Rev 103(3):403–428. Saunders AM, Schmader K, Breitner JC, Benson MD, Brown WT, Goldfarb L, et al. 1993. Apolipoprotein E epsilon 4 allele distri- butions in late-onset Alzheimer’s disease and in other amy- loid-forming diseases. Lancet 342(8873):710–711. Schafer JH, Glass TA, Bolla KI, Mintz M, Jedlicka AE, Schwartz BS. 2005a. Homocysteine and cognitive function in a popula- tion-based study of older adults. J Am Geriatr Soc 53(3): 381–388. Schafer JH, Glass TA, Bressler J, Todd AC, Schwartz BS. 2005b. Blood lead is a predictor of homocysteine levels in a popula- tion-based study of older adults. Environ Health Perspect 113:31–35. Schwartz BS, Lee BK, Bandeen-Roche K, Stewart W, Bolla K, Links J, et al. 2005. Occupational lead exposure and longitu- dinal decline in neurobehavioral test scores. Epidemiology 16(1):106–113. Schwartz BS, Lee BK, Lee GS, Stewart WF, Lee SS, Hwang KY, et al. 2001. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol 153(5):453–464. Schwartz BS, Stewart W, Hu H. 2002. Neurobehavioural testing in workers occupationally exposed to lead. Occup Environ Med 59(9):648–649. Schwartz BS, Stewart WF, Bolla KI, Simon PD, Bandeen-Roche K, Gordon PB, et al. 2000. Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology 55(8):1144–1150. Seeber A, Meyer-Baron M. 2003. Neurobehavioural testing in workers occupationally exposed to lead. Occup Environ Med 60(2):145; author reply 145–146. Seeber A, Meyer-Baron M, Schaper M. 2002. A summary of two meta-analyses on neurobehavioural effects due to occupa- tional lead exposure. Arch Toxicol 76(3):137–145. 491